PD-1 Antibody-based Therapy With Concurrent RT for Early-stage NKTCL
PD-1 Antibody-based Therapy With Concurrent RT for Early-stage NKTCL
Recruiting · NCT07380984 · Registry updated 2026-03-20Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| PD-1 Antibody-based Therapy With Concurrent RT for Early-stage NKTCL | Natural Killer/T-cell Lymphoma | Recruiting | Phase 2 | 2026-03-20 | NCT07380984 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Ruijin Hospital | 454 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Ruijin Hospital, Shanghai Jiaotong University School of Medicine | Shanghai | China | 21 |